CClinicalTrials.gg
Not yet recruitingNCT07177040Updated Oct 7, 2025

Effect of Two Different Mobilization Techniques in the Treatment of Low Back Pain

An interventional study of Maitland and SNAG in Non-specific Low Back Pain (NSLBP), sponsored by Ehab Mohamed Kamel Ahmed. Not yet recruiting at 1 site in Saudi Arabia. Open to participants aged 25 Years to 40 Years. Per ClinicalTrials.gov, last updated 2025-10-07.

Sponsored by Ehab Mohamed Kamel Ahmed · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Dec 2025, 9 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
25 Years to 40 Years
Sex
All
01

Study summary

Non-specific low back pain (NSLBP) is extensively musculoskeletal conditions, where manual therapy techniques have been widely employed in its management, but their short term efficacy in chronic low back pain still need more investigations. Objective: This study aimed to discuss the SNAG versus Maitland techniques in the management of NSLBP. Methods: 60 patients with chronic NSLBP will share in the study. Sessions will be conducted 3 times per week for 4 weeks. The outcomes will be evaluated for pain by the numerical rating pain scale (NPRS), disability through Oswestry Disability Index, flexion range of motion by back range of motion device, postural stability by Biodex system will be assessed at baseline, immediately post-intervention, and at a four-week follow-up

02

Conditions studied

  • Non-specific Low Back Pain (NSLBP)
03

In context

Lead sponsor

This is the only study on the registry with Ehab Mohamed Kamel Ahmed as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adults aged 25 to 40 years.
  • Diagnosed with chronic NSLBP persisting for more than three months.
  • Pain intensity between 3 to 6 on the Visual Analog Scale (VAS) during lumbar extension in a sitting position.
  • Oswestry Disability Index (ODI) score between 20% to 40%.
  • Restriction of the movement only in flexion ROM with the ability to perform at least 40° of trunk flexion.

Exclusion criteria

Exclusion Criteria:

  • Specific causes of low back pain (e.g., herniated disc, spinal stenosis).
  • History of spinal surgery or trauma.
  • Neurological deficits or systemic diseases affecting the musculoskeletal system.
  • Pregnancy.
  • Current participation in other physiotherapy programs.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Maitland

    Participants will receive Maitland technique therapy

    Procedure: Maitland · Procedure: SNAG

  • Active comparator
    SNAG

    Participants will receive SNAG therapy based on the Mulligan Concept

    Procedure: Maitland · Procedure: SNAG

Interventions

  • ProcedureMaitland

    Maitland technique therapy, which consists of passive mobilizations applied to the lumbar facet joints in an anterocranial direction while the patient is in a prone lying position

  • ProcedureSNAG

    The technique involves applying a sustained glide to the lumbar facet joints while the patient is in a sitting position, and the pelvic girdle will be stabilized by a belt. Then the therapist will ask the patient for active forward flexion of the spine while the pressure on the facet joint is maintained during the movement till its end

    Also known as: sustained natural apophyseal glide

06

What researchers measure

Primary outcomes

  1. Numeric Pain Rating Scale

    The NPRS will be used to evaluate the level of pain by selecting a number on a rating scale, ranging from 0 (no pain) to 10 (worst and unbearable pain).

    Time frame: 4 weeks

Secondary outcomes

  1. Functional disability

    Assessed by the Oswestry Disability Index (ODI) where according to the scale the disability will be indicated as follow: 0-4 no disability, 5-14 mild disability, 5-24 moderate disability, 25-34 severe disability, and 35-50 complete disability

    Time frame: 4 weeks

  2. Lumbar flexion range of motion

    Measured using a Back range of motion (BROM)

    Time frame: 4 weeks

  3. overall stability index (OSI)

    Repositioning error evaluated through proprioceptive testing provided by the Biodex Balance System, no need for cut off) as the measurement differences will be compared.

    Time frame: 4 weeks

07

Study locations

1 site
  • University Medical Clinics
    Ha'il, 0000, Saudi Arabia
    • Ehab Ahmed, Physiotherapist · Contact · +966564032363
08

References and documents

Individual participant data

Plan to share: No — All the data will be obtained from the experiment is under the protection of the Scientific Research Deanship, University of Ha'il, Saudi Arabia as this project is funded from it with number RG-20 202.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 7, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07177040
Lead sponsor
Ehab Mohamed Kamel Ahmed
Collaborators
The Scientific Research Deanship, University of Ha'il
Responsible party
Ehab Mohamed Kamel Ahmed (Department of Public Health, College of Public Health and Health Informatics, University of Hail, Ha'il, Saudi Arabia, University of Hail) — Sponsor-investigator
First posted
Sep 16, 2025
Start date
Oct 5, 2025 (estimated)
Primary completion
Dec 30, 2025 (estimated)
Completion
Jan 20, 2026 (estimated)
Last update
Oct 7, 2025

Study contacts

Ehab Ahmed, PhD
Contact
em.ahmed@uoh.edu.sa
+966564032363

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion